6604-76-8

Upstream product

• 26867-13-0 6-chloro-3-nitro-N-phenylpyridin-2-amine 
• 62-53-3 aniline 
• 16013-85-7 2,6-dicholoro-3-nitropyridine 

Downstream Products

• 26867-15-2 5-chloro-3-phenyl-3H-[1,2,3]triazolo[4,5-b]pyridine 
• 1331741-82-2 C₁₉H₁₇N₅ 
• 1331741-89-9 C₁₉H₁₈N₆O₂S 
• 89660-26-4 5-Chloro-1-ethyl-3-phenyl-1,3-dihydro-imidazo[4,5-b]pyridin-2-one 
• 89660-25-3 1-methyl-3-phenyl-5-chloroimidazo<4,5-b>pyridin-2-thione 
• 89660-24-2 1-methyl-3-phenyl-5-chloroimidazo<4,5-b>pyridin-2-one 
• 89660-22-0 3-phenyl-5-chloroimidazo<4,5-b>pyridin-2-one 
• 89660-23-1 3-phenyl-5-chloroimidazo<4,5-b>pyridin-2-thione 

Relevant academic research and scientific papers

IMIDAZOPYRIDINE DERIVATIVES AS PI3K INHIBITORS

New imidazopyridine derivatives having the chemical structure of formula (I) are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Phosphoinositide 3-Kinases (PI3Ks).

Hit to lead evaluation of 1,2,3-triazolo[4,5-b]pyridines as PIM kinase inhibitors

PIM kinases have become targets of interest due to their association with biochemical mechanisms affecting survival, proliferation and cytokine production. 1,2,3-Triazolo[4,5-b]pyridines were identified as PIM inhibitors applying a scaffold hopping approa

Compounds with antiulcer and antisecretory activity. III. N-substituted imidazolones condensed with nitrogen-containing heteroaromatic rings

The syntheses of imidazo[4,5-b]pyridin-2-ones and -thiones, imidazo [4,5-c]pyridin-2-ones and 7,9-dihydro-8H-purin-8-ones arylated (or heteroarylated) at an imidazolone nitrogen are reported. Only some compounds of the first series have marked antisecreto